1. Hundal R, , Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 2014; 6: 99–109. doi: https://doi.org/10.2147/CLEP.S37357

2. Epidemiology of gallbladder cancer in India - Dutta - Chinese Clinical Oncology. Available from: https://cco.amegroups.com/article/view/28518/25067

3. Dwivedi AND, , Jain S, , Dixit R. Gall bladder carcinoma: aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases 2015; 3: 231–44. doi: https://doi.org/10.12998/wjcc.v3.i3.231

4. Chaudhari VA, , Ostwal V, , Patkar S, , Sahu A, , Toshniwal A, , Ramaswamy A, , et al.. Outcome of neoadjuvant chemotherapy in “ locally advanced/borderline resectable ” gallbladder cancer: the need to define indications. HPB (Oxford) 2018; 20: 841–47: S1365-182X(18)30783-4. doi: https://doi.org/10.1016/j.hpb.2018.03.008

5. Reddy CV, , Goud YGB, , Poornima R, , Deshmane V, , Madhusudhana BA, , Gayathridevi M. Role of FNAC in hepatic lesions: risk of track metastases. South Asian J Cancer 2015; 4: 35–37. doi: https://doi.org/10.4103/2278-330X.149949

6. Tyagi R, , Dey P. Needle tract seeding: an avoidable complication. Diagn Cytopathol 2014; 42: 636–40. doi: https://doi.org/10.1002/dc.23137

7. Shyamala K, , Girish HC, , Murgod S. Risk of tumor cell seeding through biopsy and aspiration cytology. J Int Soc Prev Community Dent 2014; 4: 5–11. doi: https://doi.org/10.4103/2231-0762.129446

8. Smith EH. Complications of percutaneous abdominal fine-needle biopsy. review. Radiology 1991; 178: 253–58. doi: https://doi.org/10.1148/radiology.178.1.1984314

9. Francica G. Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge. J Hepatocell Carcinoma 2017; 4: 23–27. doi: https://doi.org/10.2147/JHC.S106558

10. Kumar S, , Singh D, , Goel MM, , Kushwaha JK. Fnac site metastasis in gall bladder cancer -- a rare presentation. BMJ Case Rep 2012; 2012: bcr0220125777. doi: https://doi.org/10.1136/bcr.02.2012.5777

11. Zhu X, , Zhang X, , Hu X, , Ren H, , Wu S, , Wu J, , et al.. Survival analysis of patients with primary gallbladder cancer from 2010 to 2015: a retrospective study based on SEER data. Medicine (Baltimore) 2020; 99(40): e22292. doi: https://doi.org/10.1097/MD.0000000000022292

12. Ozer M, , Goksu SY, , Sanford NN, , Porembka M, , Khurshid H, , Ahn C, , et al.. A propensity score analysis of chemotherapy use in patients with resectable gallbladder cancer. JAMA Netw Open 2022; 5: e2146912. doi: https://doi.org/10.1001/jamanetworkopen.2021.46912

13. Aloia TA, , Járufe N, , Javle M, , Maithel SK, , Roa JC, , Adsay V, , et al.. Gallbladder cancer: expert consensus statement. HPB (Oxford) 2015; 17: 681–90. doi: https://doi.org/10.1111/hpb.12444

14. Espinoza S, , Briggs P, , Duret J-S, , Lapeyre M, , de Baère T. Radiofrequency ablation of needle tract seeding in hepatocellular carcinoma. J Vasc Interv Radiol 2005; 16: 743–46. doi: https://doi.org/10.1097/01.RVI.0000153109.56827.70

15. Fairweather M, , Gonzalez RJ, , Strauss D, , Raut CP. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol 2018; 117: 33–41. doi: https://doi.org/10.1002/jso.24919